Skip to main content
logo
Enliven Therapeutics, Inc. (ELVN)
NASDAQ: ELVN · Real-Time Price · USD
58.82
+0.76 (1.31%)
At close: Aug 14, 2026, 4:00 PM EDT
58.94
+0.12 (0.21%)
After-hours: Aug 14, 2026, 7:34 PM EDT

Enliven Therapeutics Cash Flow Statement

Millions USD. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
-105.93-103.69-89.02-71.58-37.66-24.74
Depreciation & Amortization
0.130.260.320.30.220.12
Other Amortization
----1.74-
Loss (Gain) From Sale of Assets
0.110.110.01---
Loss (Gain) From Sale of Investments
0.52-0.230.42-4.6--
Stock-Based Compensation
40.8134.0220.1712.913.191.92
Other Operating Activities
0.40.35-0.550.31--
Change in Accounts Payable
-2.210.820.81-2.250.411.73
Change in Other Net Operating Assets
-0.76-1.94-5.353.650.031.83
Operating Cash Flow
-66.94-70.3-73.19-61.27-32.08-19.13
Operating Cash Flow Growth
------

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-0.1-0.16-0.04-0.15-0.61-0.19
Sale of Property, Plant & Equipment
0.210.21----
Investment in Securities
-390.83-173.9-36.83-148.26--
Other Investing Activities
--0.87---
Investing Cash Flow
-390.72-173.84-36-148.41-0.61-0.19

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Issuance of Common Stock
473.94219.08133.17243.590.590.69
Other Financing Activities
-0.22-0.22--9.3-2.39-1.71
Financing Cash Flow
473.73218.87133.17234.29-1.8-1.02

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Cash Flow
16.07-25.2823.9824.61-34.49-20.34

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
-67.04-70.46-73.24-61.42-32.69-19.33
Free Cash Flow Growth
------
Free Cash Flow Per Share
-1.06-1.24-1.56-1.73-10.46-2.47
Levered Free Cash Flow
-45.26-47.98-46.23-32.95-17.48-9.83
Unlevered Free Cash Flow
-45.26-47.98-46.23-32.95-17.48-9.83

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Income Tax Paid
--0.23---
Change in Working Capital
-2.98-1.12-4.541.40.443.57
SEC Filings: 10-K · 10-Q